Literature DB >> 19833460

Neonatal hyperbilirubinemia and kernicterus - not gone but sometimes forgotten.

M Jeffrey Maisels1.   

Abstract

The introduction of exchange transfusion made it possible to prevent severe hyperbilirubinemia and kernicterus, but kernicterus has never completely disappeared and it is still occurring in North America and, more frequently in Western Europe and the developing world. I discuss the epidemiology and major causes of severe hyperbilirubinemia and the potential root causes and system failures associated with the development of extreme hyperbilirubinemia and, subsequently, kernicterus. In the Western world, kernicterus remains a rare cause of cerebral palsy but, in contrast to the other causes of cerebral palsy, kernicterus should almost always be preventable. The key elements in preventing kernicterus are risk assessment and appropriate follow-up for the newborn infant and these are presented in a recently developed algorithm. Implementation of this approach might contribute to the prevention of severe hyperbilirubinemia and bilirubin encephalopathy.

Entities:  

Mesh:

Year:  2009        PMID: 19833460     DOI: 10.1016/j.earlhumdev.2009.09.003

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  15 in total

1.  Sixth hour transcutaneous bilirubin predicting significant hyperbilirubinemia in ABO incompatible neonates.

Authors:  Ramesh Y Bhat; Pavan C G Kumar
Journal:  World J Pediatr       Date:  2013-06-17       Impact factor: 2.764

2.  Exchange transfusion for hemolytic hyperbilirubinemia: could some be averted by emergent administration of an inhibitor of bilirubin production?

Authors:  Susan E Wiedmeier; Timothy M Bahr; Robin K Ohls; Thomas R Christensen; Vickie L Baer; Sarah J Ilstrup; Kelly Cail; Robert D Christensen
Journal:  J Perinatol       Date:  2020-07-15       Impact factor: 2.521

3.  Predictive value of cord blood bilirubin for hyperbilirubinemia in neonates at risk for maternal-fetal blood group incompatibility and hemolytic disease of the newborn.

Authors:  K Calkins; D Roy; L Molchan; L Bradley; T Grogan; D Elashoff; V Walker
Journal:  J Neonatal Perinatal Med       Date:  2015

4.  A decision-making tool for exchange transfusions in infants with severe hyperbilirubinemia in resource-limited settings.

Authors:  B O Olusanya; I F Iskander; T M Slusher; R P Wennberg
Journal:  J Perinatol       Date:  2016-03-03       Impact factor: 2.521

5.  Lipid peroxidation, DNA damage and total antioxidant status in neonatal hyperbilirubinemia.

Authors:  S Basu; D De; H Dev Khanna; A Kumar
Journal:  J Perinatol       Date:  2014-03-27       Impact factor: 2.521

6.  Cord blood -fetoprotein as a predictive index for indirect hyperbilirubinemia in term neonates.

Authors:  Yadollah Zahedpasha; Mousa Ahmadpour-Kacho; Jafar Khalafi; Ali Bijani
Journal:  Caspian J Intern Med       Date:  2011

Review 7.  Review of bilirubin neurotoxicity I: molecular biology and neuropathology of disease.

Authors:  Sean M Riordan; Steven M Shapiro
Journal:  Pediatr Res       Date:  2019-10-10       Impact factor: 3.756

Review 8.  High unbound bilirubin for age: a neurotoxin with major effects on the developing brain.

Authors:  Rowena Cayabyab; Rangasamy Ramanathan
Journal:  Pediatr Res       Date:  2018-12-05       Impact factor: 3.756

9.  Measurements of neonatal bilirubin and albumin concentrations: a need for improvement and quality control.

Authors:  Deirdre E van Imhoff; Peter H Dijk; Cas W Weykamp; Christa M Cobbaert; Christian V Hulzebos
Journal:  Eur J Pediatr       Date:  2011-01-07       Impact factor: 3.183

Review 10.  Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis.

Authors:  Bolajoko O Olusanya; Folasade B Osibanjo; Tina M Slusher
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.